Delphi has advised BeammWave (publ). BeammWave AB has completed a rights issue of Class B shares, raising a maximum of approximately SEK 65.0 million. The rights...
BeammWave Completes SEK 65 Million Rights Issue
BE Group Completes SEK 143 Million Rights Issue
Delphi has advised BE Group. BE Group AB (publ) has completed a rights issue involving 6,491,602 shares, raising approximately SEK 143 million before issue costs. The...
Paxman’s Acquisition of Dignitana
Delphi assisted Paxman AB on the deal. Paxman AB (publ) completed the public acquisition of Dignitana AB (publ). Through the acquisition, shares issued by Dignitana are...
Enorama Pharma’s Rights Offering
Delphi advised Enorama Pharma on the deal. Enorama Pharma AB (publ) executed a rights issue of 6,665,386 shares. Through the rights issue, Enorama Pharma is provided...
Cyclezyme’s Directed New Issue
Delphi assisted Cyclezyme on the deal. Cyclezyme completed a directed new issue of 150,000 units consisting of shares and warrants of series TO1. Each unit comprises...
Paxman’s Directed Share Offering
Delphi assisted Paxman AB on the offering. Paxman AB (publ) finalized a directed issuance of 1.9 million shares totaling SEK 123.5 million. The subscription price was...
Mapon’s Acquisition of Interkom
Delphi advised Mapon on the deal. Mapon AS finalized the acquisition of 100 percent of the shares in Interkom AB, a fleet management provider based in...
ProstaLund’s Reverse Share Split
Delphi advised ProstaLund on the deal. ProstaLund AB (publ) secured a reverse share split, whereby forty (40) shares became one share (reverse split 1:40). ProstaLund is...